WO2000065073A3 - Genetische sequenz, die für flavonsynthase ii enzyme kodiert, und deren verwendung - Google Patents

Genetische sequenz, die für flavonsynthase ii enzyme kodiert, und deren verwendung Download PDF

Info

Publication number
WO2000065073A3
WO2000065073A3 PCT/DE2000/001214 DE0001214W WO0065073A3 WO 2000065073 A3 WO2000065073 A3 WO 2000065073A3 DE 0001214 W DE0001214 W DE 0001214W WO 0065073 A3 WO0065073 A3 WO 0065073A3
Authority
WO
WIPO (PCT)
Prior art keywords
enzyme
flavon
codes
same
genetic sequence
Prior art date
Application number
PCT/DE2000/001214
Other languages
English (en)
French (fr)
Other versions
WO2000065073A2 (de
Inventor
Stefan Martens
Gert Forkmann
Original Assignee
Stefan Martens
Gert Forkmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stefan Martens, Gert Forkmann filed Critical Stefan Martens
Priority to EP00936633A priority Critical patent/EP1190077A2/de
Priority to CA002370387A priority patent/CA2370387A1/en
Priority to AU52072/00A priority patent/AU5207200A/en
Priority to JP2000614407A priority patent/JP2002542789A/ja
Publication of WO2000065073A2 publication Critical patent/WO2000065073A2/de
Publication of WO2000065073A3 publication Critical patent/WO2000065073A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • C12N9/0038—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6) with a heme protein as acceptor (1.6.2)
    • C12N9/0042—NADPH-cytochrome P450 reductase (1.6.2.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/825—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Die vorliegende Erfindung bezieht sich auf genetische Sequenzen, die für Enzyme des Flavonoidstoffwechsels kodieren, speziell für die Flavonsynthase II (FNS II) oder Derivate hiervon und deren Verwendung zur gezielten Veränderung der Blütenfarbe, zur Veränderung des Flavongehaltes bzw. -musters in Blättern, Blüten und anderen Geweben von Pflanzen und anderen Organismen und darüberhinaus die Verwendung in Expressionssystemen zur Synthese von natürlichen, funktionellen Flavonen für medizinische oder ähnliche Anwendungen, z.B. zur Krebstherapie oder Verbesserung der menschlichen Immunabwehr.
PCT/DE2000/001214 1999-04-22 2000-04-14 Genetische sequenz, die für flavonsynthase ii enzyme kodiert, und deren verwendung WO2000065073A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP00936633A EP1190077A2 (de) 1999-04-22 2000-04-14 Genetische sequenz, die für flavonsynthase ii enzyme kodiert, und deren verwendung
CA002370387A CA2370387A1 (en) 1999-04-22 2000-04-14 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same
AU52072/00A AU5207200A (en) 1999-04-22 2000-04-14 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same
JP2000614407A JP2002542789A (ja) 1999-04-22 2000-04-14 フラボンシンターゼｉｉ酵素をコードする遺伝子配列およびその使用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19918365.1 1999-04-22
DE19918365A DE19918365A1 (de) 1999-04-22 1999-04-22 Genetische Sequenz, die für Flavonsynthase II Enzyme kodiert, und deren Verwendung

Publications (2)

Publication Number Publication Date
WO2000065073A2 WO2000065073A2 (de) 2000-11-02
WO2000065073A3 true WO2000065073A3 (de) 2001-04-19

Family

ID=7905553

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2000/001214 WO2000065073A2 (de) 1999-04-22 2000-04-14 Genetische sequenz, die für flavonsynthase ii enzyme kodiert, und deren verwendung

Country Status (6)

Country Link
EP (1) EP1190077A2 (de)
JP (1) JP2002542789A (de)
AU (1) AU5207200A (de)
CA (1) CA2370387A1 (de)
DE (1) DE19918365A1 (de)
WO (1) WO2000065073A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4368005B2 (ja) * 1999-01-29 2009-11-18 インターナショナル フラワー ディベロプメンツ プロプライアタリー リミティド フラボン合成酵素をコードする遺伝子
AU2005201464C1 (en) * 1999-01-29 2008-12-11 Suntory Holdings Limited Gene encoding flavone synthase
WO2002086110A2 (de) * 2001-04-20 2002-10-31 Technische Universität München Flavonsynthase i enzyme und deren verwendung
EP1778850A4 (de) * 2004-07-10 2011-09-21 Univ New York State Res Found Herstellung von flavonoiden anhand von rekombinanten mikroorganismen
CN100422336C (zh) * 2005-06-28 2008-10-01 北京林业大学 根癌农杆菌介导的地被菊花的转基因方法
USPP21595P3 (en) * 2008-12-19 2010-12-28 International Flower Developments Pty Ltd. Dianthus plant named ‘Floriagate’
CA2865206A1 (en) * 2012-02-24 2013-08-29 Suntory Holdings Limited Torenia-originated promoter capable of acting in petals
CN114107071A (zh) * 2021-12-14 2022-03-01 山西省农业科学院园艺研究所 一种仙客来枯萎病病原菌的分离、纯化方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60199817A (ja) * 1984-03-23 1985-10-09 Rikagaku Kenkyusho 制癌剤
WO1993018155A1 (en) * 1992-03-02 1993-09-16 Kyowa Hakko Kogyo Co., Ltd. Novel plant gene
EP0633022A2 (de) * 1993-07-09 1995-01-11 Kureha Chemical Industry Co., Ltd. Chondroprotektive Flavone
JPH08104628A (ja) * 1994-10-04 1996-04-23 Sumitomo Pharmaceut Co Ltd マトリックスメタロプロテアーゼ阻害剤
JPH09224671A (ja) * 1996-02-19 1997-09-02 Mitsui Gyosai Shokubutsu Bio Kenkyusho:Kk 新規なチトクロームｐ４５０をコードするｄｎａ
WO1997032023A1 (en) * 1996-03-01 1997-09-04 Florigene Limited Genetic sequences encoding flavonoid pathway enzymes and uses therefor
WO2000044907A1 (fr) * 1999-01-29 2000-08-03 Suntory Limited Gene codant pour une flavone synthase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62215581A (ja) * 1986-03-18 1987-09-22 Koichi Shiyudo フラボンカルボン酸誘導体
US5126129A (en) * 1988-05-23 1992-06-30 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Cancer therapy using interleukin-2 and flavone compounds
US5336685A (en) * 1993-04-12 1994-08-09 Sloan-Kettering Institute For Cancer Research Use of flavonoids to treat multidrug resistant cancer cells
JP3798043B2 (ja) * 1995-07-12 2006-07-19 大鵬薬品工業株式会社 ２−チオフラボン誘導体及びその製造方法
JPH09301915A (ja) * 1996-05-08 1997-11-25 Sankyo Co Ltd フラボン及びナフタレン誘導体

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60199817A (ja) * 1984-03-23 1985-10-09 Rikagaku Kenkyusho 制癌剤
WO1993018155A1 (en) * 1992-03-02 1993-09-16 Kyowa Hakko Kogyo Co., Ltd. Novel plant gene
EP0632128A1 (de) * 1992-03-02 1995-01-04 Kyowa Hakko Kogyo Co., Ltd. Neuartiges pflanzengen
EP0633022A2 (de) * 1993-07-09 1995-01-11 Kureha Chemical Industry Co., Ltd. Chondroprotektive Flavone
JPH08104628A (ja) * 1994-10-04 1996-04-23 Sumitomo Pharmaceut Co Ltd マトリックスメタロプロテアーゼ阻害剤
JPH09224671A (ja) * 1996-02-19 1997-09-02 Mitsui Gyosai Shokubutsu Bio Kenkyusho:Kk 新規なチトクロームｐ４５０をコードするｄｎａ
WO1997032023A1 (en) * 1996-03-01 1997-09-04 Florigene Limited Genetic sequences encoding flavonoid pathway enzymes and uses therefor
WO2000044907A1 (fr) * 1999-01-29 2000-08-03 Suntory Limited Gene codant pour une flavone synthase

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
AKASHI T., ET AL.: "Identification of a cytochrome P450 cDNA encoding (2S)-flavanone", FEBS LETTERS, vol. 432, 1998, pages 287 - 290, XP002927621 *
DATABASE EMBL 23 September 1997 (1997-09-23), AYABE S.;: "Glycyrrhiza echinata CYP93B1 mRNA for cytochrome P450, complete cds, clone:CYP Ge-5.", XP002150522 *
DATABASE EMBL 26 October 1999 (1999-10-26), MARTENS S., ET AL.: "Callistephus chinensis flavone synthase II (CYP93B5) mRNA, complete cds.", XP002150524 *
DATABASE EMBL ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 21 June 1999 (1999-06-21), MARTENS, S., ET AL.: "Gerbera hybrida flavone synthase II (CYP93B2) mRNA, complete cds.", XP002150523 *
DATABASE GENESEQ 22 December 1997 (1997-12-22), "Cytochrome P450 encoding DNA.", XP002150525 *
DATABASE GENESEQ 28 March 1994 (1994-03-28), "Flavonoid-3',5'-hydroxylase gene.", XP002150526 *
DATABASE GENSEQ 27 March 1998 (1998-03-27), "Rose flavonoid 3'-hydroxylase cDNA insert of pCGP2158.", XP002150527 *
DATABASE WPI Section Ch Week 198547, Derwent World Patents Index; Class B02, AN 1985-292293, XP002150530 *
DATABASE WPI Section Ch Week 199626, Derwent World Patents Index; Class B04, AN 1996-255073, XP002150529 *
DATABASE WPI Section Ch Week 199745, Derwent World Patents Index; Class C06, AN 1997-484100, XP002150528 *
MARTENS S ET AL: "GENETIC CONTROL OF FLAVONE SYNTHASE II ACTIVITY IN FLOWERS OF GERBERA HYBRIDS", PHYTOCHEMISTRY,GB,PERGAMON PRESS, vol. 49, no. 7, 1998, pages 1953 - 1958, XP002927622, ISSN: 0031-9422 *
MARTENS, S., ET AL.: "Cloning and expression of flavone synthase II from Gerbera-hybrids", THE PLANT JOURNAL, vol. 20, no. 5, December 1999 (1999-12-01), pages 611 - 618, XP002150521 *
RICE-EVANS ET AL: "Antioxidant properties of phenolic compounds", TRENDS IN PLANT SCIENCE,GB,ELSEVIER SCIENCE, OXFORD, vol. 4, no. 2, 1 April 1997 (1997-04-01), pages 152 - 159, XP002077026, ISSN: 1360-1385 *
TANAKA Y ET AL: "METABOLIC ENGINEERINGTO MODIFY FLOWER COLOR", PLANT AND CELL PHYSIOLOGY,JAPANESE SOCIETY OF PLANT PHYSIOLOGISTS,XX, vol. 39, November 1998 (1998-11-01), pages 1119 - 1126, XP000922977, ISSN: 0032-0781 *
TOMOYOSHI AKASHI, ET AL., TWO NEW CYTOCHROME P450 CDNAS (ACCESSION NOS. AB001379 AND AB001380) FROM ELICITOR-INDUCED LICORICE (GLYCYRRHIZA ECHINATA L.) CELLS (PGR97-167). PLANT PHYSIOL. 115: 1288, XP002150520 *

Also Published As

Publication number Publication date
WO2000065073A2 (de) 2000-11-02
AU5207200A (en) 2000-11-10
CA2370387A1 (en) 2000-11-02
JP2002542789A (ja) 2002-12-17
DE19918365A1 (de) 2000-10-26
EP1190077A2 (de) 2002-03-27

Similar Documents

Publication Publication Date Title
WO2002069886A3 (en) Modified proteins, designer toxins, and methods of making thereof
WO2003000906A3 (en) Plant disease resistance genes
BR0108564A (pt) Preparações cosméticas contendo extratos vegetais
WO2004026857A3 (en) Methods of purifying cannabinoids from plant material
WO2000065073A3 (de) Genetische sequenz, die für flavonsynthase ii enzyme kodiert, und deren verwendung
Kim et al. Cloning and characterization of a flavonol synthase gene from Scutellaria baicalensis
EP1300084A3 (de) Zusammensetzung zur Behandlung von chronischer venöser Insuffizienz mit einem Extrakt aus Blättern von roten Weinreben
EP1726653A3 (de) Gene, welche für Flavon-Synthasen kodieren
WO2004058158A3 (en) Treatment of metastatic cancer with the b-subunit of shiga toxin
WO2001062781A3 (de) Homogentisatphytyltransferase
AU2001258373A1 (en) Method for identifying helicobacter antigens
AU2001265828A1 (en) Steeping process
WO2000065036A3 (de) Überexpression einer dna-sequenz codierend für eine 1-desoxy-d-xylulose-5-phosphat reduktoisomerase in pflanzen
WO2002086110A3 (de) Flavonsynthase i enzyme und deren verwendung
WO2005054222A3 (de) Flavonoid-derivat
BG103906A (en) Proteins of the virus of leaf twisting of vinetrees (type 2) and methods for their application
EP1322658A4 (de) Oligonukleotidmodulation der her-1-expression
AU3596801A (en) Murraya koenigii extracts for treating asthma
WO2002057408A8 (en) Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
WO2002087604A8 (de) Präparationen von vitamin e in kombination mit afamin
HUP0300923A2 (hu) RAF és RAS protein kinázt tartalmazó készítmények és alkalmazásuk angiogenezis módosítására
WO2003044047A3 (en) Virulence proteins of the genus yersinia and uses thereof
WO2003066852A3 (en) Plant growth modulation by drl1 and other proteins of the elongator complex
WO2004091542A3 (en) Nitrogen containing integrin targeting compounds
WO2005013890A3 (en) Function and regulation of angiopoietin-3/angiopoietin-4

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2370387

Country of ref document: CA

Kind code of ref document: A

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2000 614407

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 52072/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000936633

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 515594

Country of ref document: NZ

WWP Wipo information: published in national office

Ref document number: 2000936633

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000936633

Country of ref document: EP